Gastroenterology Doctors in Saint Peters, MO Accepting Medicare

3 Gastroenterology doctors found. Showing 1 - 3

Robert B Cusworth, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 201 Bjc Saint Peters Dr, Suite 100, Saint Peters, MO 63376 Phone: 636-916-8200    Fax: 636-947-4246

Richard A Geisman, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 201 Bjc Saint Peters Dr, Suite 100, Saint Peters, MO 63376 Phone: 636-916-8200    Fax: 636-947-4246

Harry D Burack, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5600 Mexico Rd, Suite 21, Saint Peters, MO 63376 Phone: 636-928-3858    Fax: 636-928-0592

News Archive

U.S. Ambassador to Mozambique signs PEPFAR funding agreements with CBOs

On Monday in Maputo, Mozambique, U.S. Ambassador Douglas Griffiths signed funding agreements with 29 community-based organizations that will receive a total of $1.4 million through PEPFAR's small grants program "to strengthen health systems, boost professional training and implement income generating activities for people living with or affected by HIV/AIDS," the Mozambique News Agency/AllAfrica.com reports.

Inspire fourth quarter revenues increase 2% to $30.3 million

Inspire Pharmaceuticals, announced today financial results for the fourth quarter and year ended December 31, 2010. For the quarter ended December 31, 2010, the Company reported a net loss of $4.3 million, or per common share, compared to a net loss of $2.6 million, or per common share, for the same period in 2009.

First time-motion study assesses the impact of geographic cohorting of hospitalists

Researchers from Regenstrief Institute and Indiana University School of Medicine have conducted the first time-motion study in more than a decade to assess the impact of geographic cohorting of hospitalists.

Bausch + Lomb's sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.

Read more Medical News

› Verified 4 days ago